That is according to the findings of a study presented on Friday at the European Academy of Neurology congress
Clinical trials for those drugs have shown higher average weight loss percentages than Foundayo at its highest dose
Sources Lilly TRIUMPH-1 topline release mirror with full PRNewswire text Axios, May 21, 2026: retatrutide reaches surgery-level weight loss ClinicalTrials.gov: TRIUMPH-1 (NCT05929066) Lilly TRIUMPH-4 official release, December 11, 2025 NEJM: Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial Lilly phase 2 retatrutide press release, June 26, 2023
Choose nutrient-dense foods to nourish your body effectively
Nutritional Values Composition *Reference Intake (RI) is not established for all components
However, theyre far less common than gastrointestinal symptoms, such as nausea, vomiting, or diarrhea